ATE20519T1 - Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin. - Google Patents
Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin.Info
- Publication number
- ATE20519T1 ATE20519T1 AT83400459T AT83400459T ATE20519T1 AT E20519 T1 ATE20519 T1 AT E20519T1 AT 83400459 T AT83400459 T AT 83400459T AT 83400459 T AT83400459 T AT 83400459T AT E20519 T1 ATE20519 T1 AT E20519T1
- Authority
- AT
- Austria
- Prior art keywords
- immunotoxin
- chloroquine
- cell
- product containing
- medicinal product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8204047A FR2522968B1 (fr) | 1982-03-10 | 1982-03-10 | Medicament cytotoxique forme de l'association d'a u moins une immunotoxine et de la chloroquine |
EP83400459A EP0088694B1 (de) | 1982-03-10 | 1983-03-07 | Zellgiftiges Arzneimittel enthaltend mindestens ein Immunotoxin und Chloroquin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE20519T1 true ATE20519T1 (de) | 1986-07-15 |
Family
ID=9271836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT83400459T ATE20519T1 (de) | 1982-03-10 | 1983-03-07 | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4582703A (de) |
EP (1) | EP0088694B1 (de) |
JP (1) | JPS59500370A (de) |
AT (1) | ATE20519T1 (de) |
DE (1) | DE3364240D1 (de) |
FR (1) | FR2522968B1 (de) |
NO (1) | NO834087L (de) |
WO (1) | WO1983003055A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2516794B1 (fr) * | 1981-11-20 | 1985-10-25 | Sanofi Sa | Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique |
CA1314245C (en) * | 1984-05-23 | 1993-03-09 | Franz Jansen | Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators |
FR2573656B1 (fr) * | 1984-11-29 | 1987-02-27 | Sanofi Sa | Medicament comportant en tant qu'association au moins une immunotoxine et au moins un polymere contenant du mannose |
CA1335227C (en) * | 1987-06-22 | 1995-04-11 | Wylie W. Vale, Jr. | Crf analog conjugates |
WO1990010457A1 (en) * | 1989-03-14 | 1990-09-20 | New York University | Method of treating hiv infections using immunotoxins |
US5112607A (en) * | 1991-06-05 | 1992-05-12 | The United States Of America As Represented By The Secretary Of The Army | Potentiation of immunotoxin action by Brefeldin A |
GB0507672D0 (en) * | 2005-04-15 | 2005-05-25 | Barnaba Vincenzo | Adjuvant |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2437213A1 (fr) * | 1978-09-28 | 1980-04-25 | Cm Ind | Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation |
FR2466252A2 (fr) * | 1979-10-03 | 1981-04-10 | Clin Midy | Nouveaux produits ayant notamment des proprietes anticancereuses a base de chaine a de la ricine et d'une proteine |
-
1982
- 1982-03-10 FR FR8204047A patent/FR2522968B1/fr not_active Expired
-
1983
- 1983-03-07 US US06/552,052 patent/US4582703A/en not_active Expired - Fee Related
- 1983-03-07 WO PCT/FR1983/000044 patent/WO1983003055A1/en unknown
- 1983-03-07 JP JP58500899A patent/JPS59500370A/ja active Granted
- 1983-03-07 DE DE8383400459T patent/DE3364240D1/de not_active Expired
- 1983-03-07 AT AT83400459T patent/ATE20519T1/de not_active IP Right Cessation
- 1983-03-07 EP EP83400459A patent/EP0088694B1/de not_active Expired
- 1983-11-09 NO NO834087A patent/NO834087L/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE3364240D1 (en) | 1986-07-31 |
FR2522968B1 (fr) | 1986-03-28 |
EP0088694B1 (de) | 1986-06-25 |
FR2522968A1 (fr) | 1983-09-16 |
WO1983003055A1 (en) | 1983-09-15 |
JPH0455172B2 (de) | 1992-09-02 |
NO834087L (no) | 1983-11-09 |
EP0088694A1 (de) | 1983-09-14 |
US4582703A (en) | 1986-04-15 |
JPS59500370A (ja) | 1984-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3679908D1 (de) | Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung. | |
DE3770730D1 (de) | Antikrebstherapie und zytotoxische arzneimittel fuer deren implementation. | |
ES511433A0 (es) | "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas". | |
IE862554L (en) | Pharmaceutical compositions | |
ZA917528B (en) | Nasal pharmaceutical composition. | |
ZA832135B (en) | Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof | |
MX9102353A (es) | N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen. | |
DE3070189D1 (en) | Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it | |
IT1212778B (it) | Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene. | |
BE894175A (fr) | Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent. | |
GR3035682T3 (en) | Non-glycosylated fgf-4 and compositions containing the same. | |
IL61930A (en) | 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it | |
DE3579730D1 (de) | Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE20519T1 (de) | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin. | |
MX9203148A (es) | 2,6-dialcoxipenzamidas y composiciones farmaceuticas que las contienen. | |
DE3067566D1 (en) | N-aryl-n'-imidazol-2-ylureas, process for their preparation and pharmaceutical compositions containing them | |
IT8323396A0 (it) | Antimuscarinica. composizione farmaceutica adattivita' sistemica anticolinesterasica, agonista-colinergica ed | |
IL67940A0 (en) | 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them | |
DE69104083D1 (de) | Neue Antiulcus-Substanz. | |
DE3576505D1 (de) | 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE28566T1 (de) | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin. | |
FR2521010B1 (fr) | Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent | |
ATE28323T1 (de) | Substituierte 2-hydroxyphenyl-cycloalkane und die sie enthaltenden pharmazeutischen zusammensetzungen. | |
NZ192082A (en) | 10-cyano-5h-dibenz(b,f)azepine-5-carboxamide and pharmaceutical compositions | |
DE3869232D1 (de) | Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |